CROP17 Partnership with Savills and CambridgeHOK
Hanway teams up with Savills and CambridgeHOK to help British farmers, food companies and landowners capitalise on medical cannabis opportunities
Hanway Associates is joining forces with Savills, a global real estate services provider listed on the London Stock Exchange, and CambridgeHOK, a controlled-environment agriculture construction specialist, to launch Crop17, a turnkey solution for planning, building and operating medical cannabis facilities within the UK’s regulatory framework.
Crop17 will offer an end-to-end solution for investors and businesses wishing to capitalise on the enormous growth potential of the UK’s medical cannabis market. It will provide specific geographical information about a potential cultivation site, alongside regulatory and operational consultancy in order to advise on investment decision making. The turnkey solution will vastly improve feasibility for businesses looking to become medical cannabis cultivators in the UK.
Alex Bragg of Savills at the launch of CROP17 at Savills’ HQ.
L-R: Alex Bragg, George McBride, and Patrick Harte at the launch of CROP17
George McBride, Co-Founder of Hanway Associates
“Growing cannabis legally in the UK is difficult, but far from impossible. Extensive barriers to entry guard lucrative opportunities in the nascent medical cannabis industry. Crop17 greatly reduces the risks involved in developing a commercial cultivation operation. Only 20 high-THC cannabis cultivation active licences were issued to companies between October 2018 and 2019.”
Alex Bragg Director at Savills
“The UK agriculture sector is embarking upon a period of unprecedented change. A phasing out of subsidies, a new dawn for trade, adapting to meet climate change targets and a huge growth in agtech presents the industry with huge challenges and opportunities. For the forward thinking and innovative farmer and grower adapting into new markets is a key priority. This turnkey solution is the type of innovation we expect to see more of within UK agriculture.”
Steve Hinch, Finance Director at CambridgeHOK
“We see the medical cannabis sector as a high potential growth area offering attractive returns for our customer base. Alongside working with best in class partners - in Hanway Associates and Savills - we have strengthened our management team to be able to build operational insight into our extensive history of building glasshouses and controlled environment, indoor growing facilities. We believe this collaboration offers a truly unique offering to the market place giving growers/investors a lower risk market entry.”
To speak to the Hanway team about this new venture please contact team@crop17.com or visit crop17.com. You can follow the new venture on LinkedIn.
Read about the launch on ITV, Horticulture Week, Farming UK and The Daily Mail.